Natco Pharma LtdShare price targets & analyst calls
₹828.65-9.65 (-1.15%)
As of 4 Sept 2026
Analysts split · BUY side·1 of 2 long-term calls BUY·consensus 1Y target ₹1,125 (35.8% above CMP)
₹1,125
35.8% above CMP
₹750 – ₹1,500
2 active 1Y targets
2 open
1 BUY · 1 SELL (all horizons)
N/A
9 of 10 closed calls needed
Watch NATCOPHARM for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips (11) · loading…
BUYNATCOPHARMNatco PharmaHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 12 mo left
AI5+·4−-5.9% P&L+81.0% upside left
₹828.65
CMP
Entry*
₹880.25
Target
₹1,500
CTChandan Taparia, Motilal Oswal· via ET Now (Live)1w ago
SELLNATCOPHARMNatco PharmaHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 2 mo left
AI3+·6−-2.0% P&L+9.5% upside left
₹828.65
CMP
Target
₹750
Entry*
₹812.65
ISICICI Securities· via Institutional / Brokerage Research42w ago
BUYNATCOPHARMNatco PharmaHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+22.51% realised0.0% upside left
Entry*
₹1,020.3
Target
₹1,250
hit 18 Jun 2024, 12:06 pm
ISICICI Securities· via Institutional / Brokerage Research118w ago
BUYNATCOPHARMNatco PharmaHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
-42.11% realisedNA upside left
₹811.4
At expiry
Entry*
₹1,401.65
Target
₹1,675
expired 7 Oct 2025, 3:30 pm
ISICICI Securities· via Institutional / Brokerage Research99w ago
+11.40% realised0.0% upside left
SL
₹800
Entry*
₹852.8
Target
₹950
hit 1 Jul 2026, 12:07 pm
PHPradeep Haldar, PHD Capital· via Business Today12w ago
-4.39% realisedNA upside left
SL
₹1,155
Entry
₹1,208
Target
₹1,325
hit 14 May 2026, 2:34 pm
ICIDBI Capital· via IDBI Capital Research Calls Telegram16w ago
-2.80% realisedNA upside left
SL
₹972
Entry
₹1,000
Target
₹1,150
hit 30 Mar 2026, 12:03 pm
DDDhupesh Dhameja, SAMCO Securities· via CNBC Awaaz.22w ago
BUYNATCOPHARMNatco PharmaHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
+4.81% realised0.0% upside left
SL
₹950
Entry
₹978
Target
₹1,025
hit 2 Apr 2026, 2:30 pm
ASAmit Seth· via CNBC Awaaz.23w ago
BUYNATCOPHARMNatco PharmaHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI1+·0−-1.75% realisedNA upside left
SL
₹930
Entry*
₹946.55
Target
₹1,000
hit 14 Aug 2026, 2:00 pm
PGPrakash Gaba· via CNBC Awaaz.3w ago
BUYNATCOPHARMNatco PharmaHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-1.64% realisedNA upside left
SL
₹960
Entry*
₹976
Target
₹1,000
hit 8 Jul 2026, 9:55 am
PGPrakash Gaba· via CNBC Awaaz.8w ago
BUYNATCOPHARMNatco PharmaHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI7+·0−-1.57% realisedNA upside left
₹949.85
At expiry
SL
₹940
Entry
₹965
Target
₹1,010
expired 20 Jul 2026, 3:30 pm
ICIDBI Capital· via IDBI Capital Research Calls Telegram8w ago